These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29458281)

  • 61. Clinical Utility of Select Neuropsychological Assessment Battery Tests in Predicting Functional Abilities in Dementia.
    Ashendorf L; Alosco ML; Bing-Canar H; Chapman KR; Martin B; Chaisson CE; Dixon D; Steinberg EG; Tripodis Y; Kowall NW; Stern RA
    Arch Clin Neuropsychol; 2018 Aug; 33(5):530-540. PubMed ID: 29126099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
    Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development and validation of a new performance-based measurement of instrumental activities of daily living in Taiwan.
    Chen HM; Yeh YC; Su WL; Huang MF; Chang CW; Chen CS
    Psychogeriatrics; 2015 Dec; 15(4):227-34. PubMed ID: 25515653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2.
    Springate BA; Tremont G; Papandonatos G; Ott BR
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):139-44. PubMed ID: 24578462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study.
    Gu D; Lv X; Shi C; Zhang T; Liu S; Fan Z; Tu L; Zhang M; Zhang N; Chen L; Wang Z; Wang J; Zhang Y; Li H; Wang L; Zhu J; Zheng Y; Wang H; Yu X;
    J Med Internet Res; 2023 Dec; 25():e49147. PubMed ID: 38039074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
    Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
    JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    Lauriola M; D'Onofrio G; Ciccone F; Germano C; Cascavilla L; Paris F; Greco A
    J Alzheimers Dis; 2021; 82(1):235-248. PubMed ID: 34057086
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Accuracy of a Brief Neuropsychological Battery for the Diagnosis of Dementia and Mild Cognitive Impairment: An Analysis of the NEDICES Cohort.
    Serna A; Contador I; Bermejo-Pareja F; Mitchell AJ; Fernández-Calvo B; Ramos F; Villarejo A; Benito-León J
    J Alzheimers Dis; 2015; 48(1):163-73. PubMed ID: 26401937
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study.
    Zhang W; Wang X; Lü Y; Yu W
    J Psychosom Res; 2022 Oct; 161():110994. PubMed ID: 35939891
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Informant questionnaire on cognitive decline in the elderly (IQCODE) for classifying cognitive dysfunction as cognitively normal, mild cognitive impairment, and dementia.
    Park MH
    Int Psychogeriatr; 2017 Sep; 29(9):1461-1467. PubMed ID: 28560943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impaired Cognitive Function is Associated with Motor Function and Activities of Daily Living in Mild to Moderate Alzheimer's Dementia.
    Lee G
    Curr Alzheimer Res; 2020; 17(7):680-686. PubMed ID: 32811414
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese.
    Feng X; Zhou A; Liu Z; Li F; Wei C; Zhang G; Jia J
    J Alzheimers Dis; 2018; 61(4):1611-1618. PubMed ID: 29376851
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
    Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Comparative Evaluation of the KDSQ-C, AD8, and SMCQ as a Cognitive Screening Test to Be Used in National Medical Check-ups in Korea.
    Kim A; Kim S; Park KW; Park KH; Youn YC; Lee DW; Lee JY; Lee JH; Jeong JH; Choi SH; Han HJ; Kim S; Na S; Park M; Yim HW; Yang DW
    J Korean Med Sci; 2019 Apr; 34(14):e111. PubMed ID: 30977313
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characteristics of two telephone screens for cognitive impairment.
    Järvenpää T; Rinne JO; Räihä I; Koskenvuo M; Löppönen M; Hinkka S; Kaprio J
    Dement Geriatr Cogn Disord; 2002; 13(3):149-55. PubMed ID: 11893836
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.